SCHEDULE: Nantahala Capital Amends enVVeno Medical Stake

Nantahala Capital Management and its managing members reported a 3.46% beneficial ownership stake in enVVeno Medical Corporation as of September 30, 2025.

Summary

• Nantahala Capital Management, LLC, along with its managing members Wilmot B. Harkey and Daniel Mack, reported beneficial ownership of 688,940 shares of enVVeno Medical Corporation's common stock.
• This ownership represents 3.46% of the total class of securities outstanding.
• The reporting persons share both voting and dispositive power over all 688,940 shares.
• The filing is an Amendment No. 2 to a Schedule 13G, indicating previous filings regarding their ownership.
• The securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: This is a routine beneficial ownership filing (Schedule 13G Amendment), which is purely factual and does not inherently convey positive or negative sentiment regarding the company's performance or prospects. It simply reports a specific ownership stake.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Provides transparency regarding significant institutional ownership, confirming a specific investment firm's stake.

Key Dates

Keywords

enVVeno Medical Corporation, Nantahala Capital Management, Beneficial Ownership, Schedule 13G, Common Stock, Investment Adviser, Wilmot B. Harkey, Daniel Mack